EUCALYPTUS TINCTURE

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT EUCALYPTUS TINCTURE

Composition:

Active substance: eucalyptus leaf tincture (Eucalypti folium) (1 : 5) (extraction solvent – 70% ethanol);

1 vial contains eucalyptus leaf tincture (Eucalypti folium) (1 : 5) (extraction solvent – 70% ethanol) – 25 ml.

Pharmaceutical form. Tincture.

Main physicochemical properties: clear greenish-brown liquid with a characteristic odor.

Pharmacotherapeutic group. Antiseptics. ATC code A01A D11.

Pharmacological Properties

Pharmacodynamics

The medicinal product is a traditional herbal medicinal product for use according to indications established by long-standing use.

Eucalyptus tincture contains tannins, ellagic acid, flavonoids, resins, wax, and essential oil, which includes various terpenoid compounds. These components are particularly active against Gram-positive and Gram-negative microorganisms and have a detrimental effect on fungi and protozoa. Eucalyptus inhibits the growth of Staphylococcus aureus, Escherichia species, Mycobacterium tuberculosis, trichomonads, and Entamoeba histolytica. The main component of the essential oil is cineole (a monocyclic terpene). The antiseptic, anti-inflammatory, and disinfectant effects of Eucalyptus tincture are due to the oxidative effect of cineole and the anti-inflammatory action associated with virtually all physiologically active substances present in its composition. The preparation also exerts a moderate sedative (calming) effect.

Pharmacokinetics. Not established.

Clinical characteristics.

Indications.

Inflammatory diseases of the upper respiratory tract, nasopharynx, and oral cavity (tracheitis, laryngitis, pharyngitis, gingivitis, stomatitis), skin injuries (including infected wounds), as well as mild forms of neurotic disorders (irritability, emotional lability, difficulty falling asleep and sleep disturbances).

Contraindications.

Bronchial asthma, bronchospasm. Inflammatory diseases of the gastrointestinal tract and biliary tract. Severe liver disease. Individual hypersensitivity to the components of the drug.

Interaction with other medicinal products and other types of interactions. Unknown.

Special precautions for use.

Since the formulation contains ethanol, the tincture is not recommended for prolonged use.

Use during pregnancy or breastfeeding.

Since the formulation contains ethanol, the tincture is not recommended for oral use in women during pregnancy or breastfeeding.

Ability to affect reaction speed when driving or operating machinery.

When taking Eucalyptus tincture orally, caution should be exercised when driving vehicles or operating potentially hazardous machinery.

Dosage and Administration.

"Eucalyptus Tincture" is taken orally, as well as used for mouthwashes and steam inhalations.

Adults are recommended to take 15–30 drops of the tincture orally 3–4 times daily after meals. Children aged 12 years and older should take 1 drop per year of life, 3–4 times daily after meals. For mouthwashes, dilute 10–15 drops of the tincture in 200 mL of warm boiled water. For steam inhalations, use the "Eucalyptus Tincture" undiluted or diluted with water (as for mouthwashes) with inhalers of any type. The duration of treatment depends on the therapeutic effect achieved.

The user should consult a physician if symptoms of the disease do not resolve during treatment or if adverse reactions occur that are not listed in the instructions for medical use of the medicinal product.

Children. Not to be used orally in children under 12 years of age due to ethanol content.

Overdose. Not established.

Side effects.

Immune system reactions: allergic reactions (including urticaria, redness and skin rash, itching, angioedema) may occur in cases of hypersensitivity to the drug; sometimes contact dermatitis (in the lip area).

Gastrointestinal disorders: nausea, vomiting, and diarrhea.

If pronounced reactions occur, discontinue use of the drug.

Shelf life. 5 years.

Storage conditions. Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging. 25 ml in bottles.

Availability. Over-the-counter.

Manufacturer. JSC "FITOPHARM".

Manufacturer's address and location of business activity.

2 Sybirtseva Street, Bakhmut, Donetsk Oblast, 84500, Ukraine.

Marketing Authorization Holder. JSC "FITOPHARM".

Address of the Marketing Authorization Holder.

7 Verkhovnoi Rady Boulevard, Kyiv, 02100, Ukraine, Building 7, Floor 3, Premises 18.